Mediseek
en_ENfr_FR

Browse by alphabet

0 1 2 3 4 5 6 7 8 9
A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z

Common search terms

- ecchymosis
- embryonary
- thymidylate synthase
- nisoldipine
- genital herpes simplex
- caproyl
- calcitonin salmon injection
- interbrain
- oesophageal dysrhythmia
- xiphisternal joint
- working occlusion
- ca2
- neck injuries
- myopia
- penicillanic acid
- dextromethorphan
- secretor
- encephalomyelitis virus, avian
- active immunity
- postural vertigo
 
Pages for xenograft
>
 

Xenograft tumor models

High-quality cost effective service for preclinical cancer animal model (Sponsored Link)
http://www.crownbio.com/
>
 

vivoPharm Preclinical CRO

Oncology, Efficacy, GLP, Toxicology in vivo, in vitro, PD PK (Sponsored Link)
http://www.vivopharm.com.au/
21
 

ACVP > 2006 ACVP Annual Meeting

American College of Veterinary Pathologists > / 2006 ACVP Annual Meeting ... Our data indicates that the combination of PS-341 and 17-AAG promotes apoptosis of the ATL cell line, both in vitro and in the xenograft NOD/SCID...
http://www.acvp.org/meeting/2006/awardstarostwinner.php
22
 

Research Groups - Newcastle Biomedicine - Newcastle University

Skip to Content / Skip to Navigation ... In vivo, nontoxic doses of AG14361 increased the delay of LoVo xenograft growth induced by irinotecan, x-irradiation, or temozolomide by two- to threefold. The combination of AG14361...
http://www.ncl.ac.uk/biomedicine/research/groups/publication/18547
23
 

Gene Directed Enzyme Prodrug Therapy (GDEPT)

The Institute of Cancer Research / From concept to cure / Home / About Us / Research / Education / Jobs / Support Us / News / Contact Us / Centenary 2009 / Search: / You are here: / Home » / Research » ... A range of prodrugs causes a dramatic...
http://cbc.icr.ac.uk/research/research_sections/cancer_therapeutics/cancer_therapeutics_teams/gene_and_oncogene_targeting/GDEPT/1739.shtml
24
 

Transplanting porcine hearts to humans -- Bach and Thomas 312 (7032): 651 -- BMJ

Jump to: Page Content, Site Navigation, Site Search, ... Endothelial cell activation leads to thrombosis and inflammation,5 both of which are evident in a rejected discordant xenograft. ... Platt JL. A perspective on...
http://www.bmj.com/cgi/content/full/312/7032/651
25
 

Cancer Immunity 6:10 (2006) - Abstract

LATEST PAPERS / SEARCH for PAPERS / View FULL TEXT ... Finally, in subcutaneous cancer xenograft models endosialin re-appears in the host-derived tumor stroma, both in neo-angiogenic vascular endothelium and in activated...
http://www.cancerimmunity.org/v6p10/060610_abs.htm
26
 

Interaction between cellular retinoic acid-binding protein II and histone hypoacetylation in renal cell carcinoma - Cogprints

Cogprints / Home / About / Browse by Year / Browse by Subject / Login | / Create Account ... 3. Touma SE, Goldberg JS, Moench P, Guo X, Tickoo SK, Gudas LJ, Nanus DM. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the...
http://cogprints.org/6088/
27
 

eMedicine - Penile Fracture and Trauma : Article by Richard A SantuccieMedicine - Penile Fracture and Trauma : Article by

Home / Specialties / Reference Centers / All Sources eMedicine Medscape Drug Reference MEDLINE / Quick Find / Authors & Editors / Introduction / Indications / Relevant Anatomy / Contraindications ... Larger defects may require placement of...
http://www.emedicine.com/med/topic3415.htm
28
 

Millennium |Research and Development |Oncology |Development Candidates

Cancer Overview / Development Candidates / Discovery Research / Alliances / Team / DEVELOPMENT CANDIDATES ... MLN8054 is a novel small molecule inhibitor of Aurora kinase(s) and exhibits potent anti-tumor activity against a variety of human tumor...
http://www.mlnm.com/rd/oncology/candidates/index.asp
29
 

Millennium |Clinicians |Oncology |Research and Development

Overview / VELCADE® / Research and Development / Clinical Trials / Resources for Patients / OTHER R&D PROGRAMS ... MLN8054 is a novel small molecule inhibitor of Aurora kinase(s) and exhibits potent anti-tumor activity against a variety of...
http://www.millennium.com/clinicians/oncology/rd/index.asp
30
 

Dr. D. Berk

D Berk AB BE(Dartmouth) PhD(Duke) / Tel: +44 (0)161 275 2375 / FAX: +44 (0)161 275 2396 / E-mail: David. Berk@man.ac.uk ... Direct in vivo measurement of targeted binding in a human tumor xenograft. Proc. Natl. Acad. ...
http://www.pharmweb.net/pwmirror/pw2/berk.html
 
 
 
< | 1 | 2 | 3 | 4 | 5 | 6 | 7 | >
 
 
Helpful links | About Mediseek | Company | Privacy policy | Contact
Vertical portal made by
www.seekport.biz

© 2007, Seekport Internet Technologies UK Ltd
Seekport Internet Technologies GmbH